Clinical Trials Directory

Explore 12,749 clinical trials worldwide

Showing 51-100 of 12,749 trials

Active filters:Phase: Phase 2Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (12,749)

NCT07060417
Vascular Effects of SGLT2i in Non-diabetic CKD
PHASE2Not yet recruiting
52 participants
Started: Apr 1, 2026 · Completed: Sep 30, 2029
1 condition1 sponsor1 location
NCT06318403
Estradiol Supplementation and Rotator Cuff Repair
PHASE2Not yet recruiting
58 participants
Started: Mar 31, 2026 · Completed: Dec 31, 2028
5 conditions1 sponsor0 locations
NCT06286046
A Study of Mitapivat in Participants With Sickle Cell Disease and Nephropathy
PHASE2Not yet recruiting
40 participants
Started: Mar 31, 2026 · Completed: Dec 31, 2028
2 conditions1 sponsor0 locations
NCT06855043
Little Lungs Study
PHASE2Not yet recruiting
30 participants
Started: Mar 31, 2026 · Completed: Jan 31, 2028
2 conditions2 sponsors2 locations
NCT05029336
Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
PHASE2Recruiting
20 participants
Started: Mar 31, 2026 · Completed: May 31, 2031
2 conditions1 sponsor1 location
NCT07178301
Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial
PHASE2Not yet recruiting
100 participants
Started: Mar 20, 2026 · Completed: Mar 20, 2031
2 conditions2 sponsors1 location
NCT06137638
ENA-001 for Post Operative Respiratory Depression (PORD)
PHASE2Not yet recruiting
200 participants
Started: Mar 15, 2026 · Completed: Dec 15, 2026
1 condition1 sponsor0 locations
NCT07216950
Knowledge and Interpersonal Skills to Develop Enhanced Relationships (KINDER)
PHASE2Not yet recruiting
260 participants
Started: Mar 11, 2026 · Completed: May 11, 2029
5 conditions2 sponsors1 location
NCT07214987
PDT For Induction Therapy For Head And Neck Cancer
PHASE2Not yet recruiting
26 participants
Started: Mar 9, 2026 · Completed: Sep 1, 2029
3 conditions2 sponsors2 locations
NCT07206290
Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease
PHASE2Not yet recruiting
120 participants
Started: Mar 2, 2026 · Completed: Nov 30, 2027
1 condition1 sponsor0 locations
NCT07215858
BPL-1357 Against H1N1 Influenza Virus Challenge
PHASE2Not yet recruiting
126 participants
Started: Mar 2, 2026 · Completed: Mar 1, 2028
2 conditions1 sponsor2 locations
NCT07169695
A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis
PHASE2Not yet recruiting
120 participants
Started: Mar 2, 2026 · Completed: Jan 21, 2027
1 condition1 sponsor0 locations
NCT07111117
Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma.
PHASE2Not yet recruiting
30 participants
Started: Mar 1, 2026 · Completed: Sep 30, 2028
1 condition1 sponsor3 locations
NCT06704100
Oral Fosamprenavir + Sodium Alginate for GERD
PHASE2Not yet recruiting
60 participants
Started: Mar 1, 2026 · Completed: Jun 1, 2028
2 conditions1 sponsor1 location
NCT07218302
Eating Disorder Chatbot Optimization
PHASE2Not yet recruiting
800 participants
Started: Mar 1, 2026 · Completed: Jul 31, 2029
1 condition3 sponsors1 location
NCT07206849
Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
PHASE2Not yet recruiting
79 participants
Started: Mar 1, 2026 · Completed: Mar 1, 2037
7 conditions1 sponsor0 locations
NCT06809153
Putting Children First - Parent Training for Parents in High Conflict
PHASE2Not yet recruiting
500 participants
Started: Mar 1, 2026 · Completed: Jan 1, 2027
4 conditions1 sponsor0 locations
NCT07209371
Rifaximin Versus No Intervention for the Treatment of IgA Monoclonal Gammopathy of Undetermined Significance
PHASE2Not yet recruiting
50 participants
Started: Mar 1, 2026 · Completed: May 1, 2028
1 condition2 sponsors1 location
NCT07158489
Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC
PHASE2Not yet recruiting
47 participants
Started: Mar 1, 2026 · Completed: Mar 31, 2029
2 conditions1 sponsor7 locations
NCT03567824
MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus
PHASE2Not yet recruiting
200 participants
Started: Mar 1, 2026 · Completed: Apr 30, 2028
1 condition1 sponsor0 locations
NCT07214103
Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy
PHASE2Not yet recruiting
120 participants
Started: Mar 1, 2026 · Completed: Dec 31, 2032
2 conditions1 sponsor1 location
NCT07139405
TRIGLYTZA® VERSUS METFORMIN IN OBESE ADULT TYPE 2 DIABETES (T2DM) PATIENTS OVER 24 WEEKS OF TREATMENT
PHASE2Not yet recruiting
90 participants
Started: Feb 28, 2026 · Completed: Jun 30, 2028
1 condition1 sponsor0 locations
NCT07162480
Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)
PHASE2Not yet recruiting
28 participants
Started: Feb 28, 2026 · Completed: Dec 31, 2031
1 condition2 sponsors1 location
NCT07219459
Visugromab, Nivolumab and a Tyrosine Kinase Inhibitor (TKI) Compared to Double Placebo and a TKI in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
PHASE2Not yet recruiting
104 participants
Started: Feb 28, 2026 · Completed: Sep 30, 2031
3 conditions1 sponsor1 location
NCT07153796
A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
PHASE2Not yet recruiting
60 participants
Started: Feb 28, 2026 · Completed: Sep 30, 2033
1 condition2 sponsors1 location
NCT07123090
A Phase 2 Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
PHASE2Not yet recruiting
25 participants
Started: Feb 28, 2026 · Completed: Feb 1, 2028
6 conditions2 sponsors2 locations
NCT07123649
Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study
PHASE2Not yet recruiting
364 participants
Started: Feb 28, 2026 · Completed: Sep 30, 2029
1 condition2 sponsors1 location
NCT06917001
Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2)
PHASE2Not yet recruiting
120 participants
Started: Feb 28, 2026 · Completed: Dec 31, 2027
1 condition2 sponsors2 locations
NCT07137481
Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies
PHASE2Not yet recruiting
70 participants
Started: Feb 28, 2026 · Completed: Jul 31, 2032
1 condition1 sponsor1 location
NCT07164469
Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma
PHASE2Not yet recruiting
100 participants
Started: Feb 28, 2026 · Completed: Sep 30, 2033
2 conditions2 sponsors1 location
NCT07187778
Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)
PHASE2Not yet recruiting
10 participants
Started: Feb 28, 2026 · Completed: Jul 19, 2029
1 condition2 sponsors1 location
NCT07192237
Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia
PHASE2Not yet recruiting
40 participants
Started: Feb 27, 2026 · Completed: Oct 12, 2032
3 conditions2 sponsors1 location
NCT07178912
Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)
PHASE2Not yet recruiting
60 participants
Started: Feb 27, 2026 · Completed: Sep 30, 2031
5 conditions3 sponsors1 location
NCT07153497
Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)
PHASE2Not yet recruiting
132 participants
Started: Feb 26, 2026 · Completed: Apr 26, 2030
2 conditions1 sponsor0 locations
NCT07169617
Testing the SurVaxM Vaccine for Lung Cancer Prevention
PHASE2Not yet recruiting
80 participants
Started: Feb 25, 2026 · Completed: Sep 30, 2027
1 condition1 sponsor4 locations
NCT06804655
Pharmacoscopy for Patients With Refractory Primary Brain Tumors
PHASE2Not yet recruiting
40 participants
Started: Feb 12, 2026 · Completed: Sep 15, 2028
8 conditions4 sponsors3 locations
NCT07133425
A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer
PHASE2Not yet recruiting
29 participants
Started: Feb 5, 2026 · Completed: Feb 1, 2030
2 conditions2 sponsors1 location
NCT06696755
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
PHASE2Not yet recruiting
195 participants
Started: Feb 5, 2026 · Completed: Nov 30, 2027
2 conditions1 sponsor0 locations
NCT06820138
Focused Ultrasound for PTSD in Veterans
PHASE2Not yet recruiting
60 participants
Started: Feb 2, 2026 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT05402332
Evaluating the Efficacy and Safety of D-galactose in PGM1-CDG (AVTX-801)
PHASE2Not yet recruiting
8 participants
Started: Feb 2, 2026 · Completed: Mar 2, 2028
1 condition2 sponsors1 location
NCT05776381
The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp
PHASE2Not yet recruiting
110 participants
Started: Feb 1, 2026 · Completed: Feb 1, 2030
6 conditions1 sponsor0 locations
NCT07152626
Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo
PHASE2Not yet recruiting
56 participants
Started: Feb 1, 2026 · Completed: Apr 1, 2029
1 condition1 sponsor1 location
NCT07148947
Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms
PHASE2Not yet recruiting
27 participants
Started: Feb 1, 2026 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT07207785
PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma
PHASE2Not yet recruiting
56 participants
Started: Feb 1, 2026 · Completed: Feb 1, 2030
1 condition1 sponsor20 locations
NCT04003285
Allopregnanolone in Chronic Complex Traumatic Brain Injury
PHASE2Not yet recruiting
132 participants
Started: Feb 1, 2026 · Completed: Feb 1, 2027
1 condition1 sponsor1 location
NCT06727786
Serious Game to Teach Opioid Overdose Response
PHASE2Not yet recruiting
850 participants
Started: Feb 1, 2026 · Completed: Dec 1, 2027
1 condition1 sponsor0 locations
NCT06408246
ACE-D: Accelerating Cognition-guided Signatures to Enhance Translation in Depression: Clinical Trial
PHASE2Not yet recruiting
160 participants
Started: Feb 1, 2026 · Completed: Feb 1, 2029
1 condition1 sponsor2 locations
NCT07143968
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
PHASE2Not yet recruiting
120 participants
Started: Jan 31, 2026 · Completed: Jan 31, 2028
2 conditions1 sponsor0 locations
NCT03643367
Sevoflurane Sedation in Patients With Septic Shock
PHASE2Not yet recruiting
153 participants
Started: Jan 31, 2026 · Completed: Nov 30, 2027
1 condition4 sponsors4 locations
NCT07191977
Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinoma
PHASE2Not yet recruiting
41 participants
Started: Jan 31, 2026 · Completed: Dec 31, 2029
1 condition1 sponsor0 locations